Marinus Pharmaceuticals reported 1.79M in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 134.56M 19.1M
ALKERMES ALKS:US $ 276.22M 2.33M
Amgen AMGN:US $ 6594M 356M
Biogen BIIB:US $ 2589.1M 57.3M
Eisai 4523:JP Y 184262M 6639M
Enanta Pharmaceuticals ENTA:US $ 19.48M 0.76M
Esperion Therapeutics ESPR:US $ 18.84M 5K
Gilead Sciences GILD:US $ 6260M 330M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
Intra Cellular Therapies ITCI:US $ 55.58M 20.58M
Marinus Pharmaceuticals MRNS:US 1.79M 12.4M
Neurocrine Biosciences NBIX:US $ 378.2M 67.6M
Ptc Therapeutics PTCT:US $ 165.53M 16.79M
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Sarepta Therapeutics SRPT:US $ 233.49M 22.66M
Supernus Pharmaceuticals SUPN:US $ 170.05M 17.55M
Vertex Pharmaceuticals VRTX:US $ 2196.2M 98.7M
YTE INCY:US $ 911.4M 178.16M